Cargando…

Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy

Introduction: The effects of spinal bulbar muscular atrophy (SBMA) on quality of life (QoL) are not well understood. This study describes symptoms from the patient's perspective and the impact these symptoms have on QoL. Methods: We conducted open‐ended interviews with 21 adult men with genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Guber, Robert D., Kokkinis, Angela D., Schindler, Alice B., Bendixen, Roxanna M., Heatwole, Chad R., Fischbeck, Kenneth H., Grunseich, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763365/
https://www.ncbi.nlm.nih.gov/pubmed/28877556
http://dx.doi.org/10.1002/mus.25957
_version_ 1783291871905185792
author Guber, Robert D.
Kokkinis, Angela D.
Schindler, Alice B.
Bendixen, Roxanna M.
Heatwole, Chad R.
Fischbeck, Kenneth H.
Grunseich, Christopher
author_facet Guber, Robert D.
Kokkinis, Angela D.
Schindler, Alice B.
Bendixen, Roxanna M.
Heatwole, Chad R.
Fischbeck, Kenneth H.
Grunseich, Christopher
author_sort Guber, Robert D.
collection PubMed
description Introduction: The effects of spinal bulbar muscular atrophy (SBMA) on quality of life (QoL) are not well understood. This study describes symptoms from the patient's perspective and the impact these symptoms have on QoL. Methods: We conducted open‐ended interviews with 21 adult men with genetically confirmed SBMA. Using a qualitative framework technique, we coded and analyzed interviews to identify symptoms and resulting themes. Results: From these interviews, 729 quotations were extracted. We identified 200 SBMA‐specific symptoms and 20 symptomatic themes. Weakness was mentioned by all interviewees. Symptoms within the domain of mental health and the specific themes of emotional issues and psychological impact were also frequently mentioned. Discussion: Numerous symptoms affect QoL for patients with SBMA. We identified previously unrecognized symptoms that are important to address in enhancing clinical care for patients with SBMA and in developing tools to evaluate efficacy in future clinical trials. Muscle Nerve 57: 40–44, 2018
format Online
Article
Text
id pubmed-5763365
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57633652018-01-17 Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy Guber, Robert D. Kokkinis, Angela D. Schindler, Alice B. Bendixen, Roxanna M. Heatwole, Chad R. Fischbeck, Kenneth H. Grunseich, Christopher Muscle Nerve Clinical Research Introduction: The effects of spinal bulbar muscular atrophy (SBMA) on quality of life (QoL) are not well understood. This study describes symptoms from the patient's perspective and the impact these symptoms have on QoL. Methods: We conducted open‐ended interviews with 21 adult men with genetically confirmed SBMA. Using a qualitative framework technique, we coded and analyzed interviews to identify symptoms and resulting themes. Results: From these interviews, 729 quotations were extracted. We identified 200 SBMA‐specific symptoms and 20 symptomatic themes. Weakness was mentioned by all interviewees. Symptoms within the domain of mental health and the specific themes of emotional issues and psychological impact were also frequently mentioned. Discussion: Numerous symptoms affect QoL for patients with SBMA. We identified previously unrecognized symptoms that are important to address in enhancing clinical care for patients with SBMA and in developing tools to evaluate efficacy in future clinical trials. Muscle Nerve 57: 40–44, 2018 John Wiley and Sons Inc. 2017-09-25 2018-01 /pmc/articles/PMC5763365/ /pubmed/28877556 http://dx.doi.org/10.1002/mus.25957 Text en © 2017 The Authors. Muscle & Nerve Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Clinical Research
Guber, Robert D.
Kokkinis, Angela D.
Schindler, Alice B.
Bendixen, Roxanna M.
Heatwole, Chad R.
Fischbeck, Kenneth H.
Grunseich, Christopher
Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy
title Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy
title_full Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy
title_fullStr Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy
title_full_unstemmed Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy
title_short Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy
title_sort patient‐identified impact of symptoms in spinal and bulbar muscular atrophy
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763365/
https://www.ncbi.nlm.nih.gov/pubmed/28877556
http://dx.doi.org/10.1002/mus.25957
work_keys_str_mv AT guberrobertd patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy
AT kokkinisangelad patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy
AT schindleraliceb patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy
AT bendixenroxannam patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy
AT heatwolechadr patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy
AT fischbeckkennethh patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy
AT grunseichchristopher patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy